The introduction of new vaccines into developing countries. IV

Global Access Strategies

Richard T. Mahoney, Anatole Krattiger, John D. Clemens, Roy Curtiss

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

This paper offers a framework for managing a comprehensive Global Access Strategy for new vaccines in developing countries. It is aimed at strengthening the ability of public-sector entities to reach their goals. The Bill and Melinda Gates Foundation and The Rockefeller Foundation have been leaders in stimulating the creation of new organizations - public/private product development partnerships (PDPs) - that seek to accelerate vaccine development and distribution to meet the health needs of the world's poor. Case studies of two of these PDPs - the Salmonella Anti-pneumococcal Vaccine Program and the Pediatric Dengue Vaccine Initiative - examine development of such strategies. Relying on the application of innovation theory, the strategy leads to the identification of six Components of Innovation which cover all aspects of the vaccine innovation process. Appropriately modified, the proposed framework can be applied to the development and introduction of other products in developing countries including drugs, and nutritional and agricultural products.

Original languageEnglish (US)
Pages (from-to)4003-4011
Number of pages9
JournalVaccine
Volume25
Issue number20
DOIs
StatePublished - May 16 2007

Fingerprint

Developing Countries
developing countries
Vaccines
vaccines
product development
Dengue Vaccines
Pneumococcal Vaccines
Public Sector
Salmonella
public sector
dengue
vaccine development
agricultural products
Organizations
Pediatrics
case studies
drugs
Pharmaceutical Preparations
Global Health

Keywords

  • Access
  • Developing country
  • Innovation
  • Vaccine

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

The introduction of new vaccines into developing countries. IV : Global Access Strategies. / Mahoney, Richard T.; Krattiger, Anatole; Clemens, John D.; Curtiss, Roy.

In: Vaccine, Vol. 25, No. 20, 16.05.2007, p. 4003-4011.

Research output: Contribution to journalArticle

Mahoney, RT, Krattiger, A, Clemens, JD & Curtiss, R 2007, 'The introduction of new vaccines into developing countries. IV: Global Access Strategies', Vaccine, vol. 25, no. 20, pp. 4003-4011. https://doi.org/10.1016/j.vaccine.2007.02.047
Mahoney, Richard T. ; Krattiger, Anatole ; Clemens, John D. ; Curtiss, Roy. / The introduction of new vaccines into developing countries. IV : Global Access Strategies. In: Vaccine. 2007 ; Vol. 25, No. 20. pp. 4003-4011.
@article{dc9c8b794c1b4141bedd94f13280bc90,
title = "The introduction of new vaccines into developing countries. IV: Global Access Strategies",
abstract = "This paper offers a framework for managing a comprehensive Global Access Strategy for new vaccines in developing countries. It is aimed at strengthening the ability of public-sector entities to reach their goals. The Bill and Melinda Gates Foundation and The Rockefeller Foundation have been leaders in stimulating the creation of new organizations - public/private product development partnerships (PDPs) - that seek to accelerate vaccine development and distribution to meet the health needs of the world's poor. Case studies of two of these PDPs - the Salmonella Anti-pneumococcal Vaccine Program and the Pediatric Dengue Vaccine Initiative - examine development of such strategies. Relying on the application of innovation theory, the strategy leads to the identification of six Components of Innovation which cover all aspects of the vaccine innovation process. Appropriately modified, the proposed framework can be applied to the development and introduction of other products in developing countries including drugs, and nutritional and agricultural products.",
keywords = "Access, Developing country, Innovation, Vaccine",
author = "Mahoney, {Richard T.} and Anatole Krattiger and Clemens, {John D.} and Roy Curtiss",
year = "2007",
month = "5",
day = "16",
doi = "10.1016/j.vaccine.2007.02.047",
language = "English (US)",
volume = "25",
pages = "4003--4011",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "20",

}

TY - JOUR

T1 - The introduction of new vaccines into developing countries. IV

T2 - Global Access Strategies

AU - Mahoney, Richard T.

AU - Krattiger, Anatole

AU - Clemens, John D.

AU - Curtiss, Roy

PY - 2007/5/16

Y1 - 2007/5/16

N2 - This paper offers a framework for managing a comprehensive Global Access Strategy for new vaccines in developing countries. It is aimed at strengthening the ability of public-sector entities to reach their goals. The Bill and Melinda Gates Foundation and The Rockefeller Foundation have been leaders in stimulating the creation of new organizations - public/private product development partnerships (PDPs) - that seek to accelerate vaccine development and distribution to meet the health needs of the world's poor. Case studies of two of these PDPs - the Salmonella Anti-pneumococcal Vaccine Program and the Pediatric Dengue Vaccine Initiative - examine development of such strategies. Relying on the application of innovation theory, the strategy leads to the identification of six Components of Innovation which cover all aspects of the vaccine innovation process. Appropriately modified, the proposed framework can be applied to the development and introduction of other products in developing countries including drugs, and nutritional and agricultural products.

AB - This paper offers a framework for managing a comprehensive Global Access Strategy for new vaccines in developing countries. It is aimed at strengthening the ability of public-sector entities to reach their goals. The Bill and Melinda Gates Foundation and The Rockefeller Foundation have been leaders in stimulating the creation of new organizations - public/private product development partnerships (PDPs) - that seek to accelerate vaccine development and distribution to meet the health needs of the world's poor. Case studies of two of these PDPs - the Salmonella Anti-pneumococcal Vaccine Program and the Pediatric Dengue Vaccine Initiative - examine development of such strategies. Relying on the application of innovation theory, the strategy leads to the identification of six Components of Innovation which cover all aspects of the vaccine innovation process. Appropriately modified, the proposed framework can be applied to the development and introduction of other products in developing countries including drugs, and nutritional and agricultural products.

KW - Access

KW - Developing country

KW - Innovation

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=34247208505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247208505&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2007.02.047

DO - 10.1016/j.vaccine.2007.02.047

M3 - Article

VL - 25

SP - 4003

EP - 4011

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 20

ER -